A Phase 1/2 Trial for Patients With Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide, and BMX-001
Phase of Trial: Phase I/II
Latest Information Update: 09 Dec 2016
At a glance
- Drugs BMX 001 (Primary) ; Temozolomide (Primary)
- Indications Glioma
- Focus Adverse reactions; Therapeutic Use
- Acronyms BMX-HGG
- Sponsors BioMimetix
- 05 Dec 2016 Planned End Date changed from 1 Feb 2019 to 1 Feb 2022.
- 05 Dec 2016 Planned primary completion date changed from 1 Feb 2018 to 1 Feb 2021.
- 02 May 2016 Status changed from not yet recruiting to recruiting.